Evaluation of cinacalcet HCL treatment after kidney transplantation

Transplantation Proceedings

Volumn 42, Issue 7, 2010, Pages 2503-2508

  Copley, J B ^a   Germain, M ^b   Stern, L ^c   Pankewycz, O ^d   Katznelson, S ^e   Shah, T ^f   Wang, O ^g   Turner, S A ^g   Sprague, S M ^h  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b Western New England Renal and Transplant Associates   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f National Institute of Transplantation Los Angeles   (United States)

^g AMGEN INC   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MINERAL METABOLISM; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BONE AND BONES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; NAPHTHALENES; PARATHYROID HORMONE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 77956495287     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.04.052     Document Type: Article

References (46)

1. R.A. Wolfe, V.B. Ashby, and E.L. Milford Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant N Engl J Med 341 1999 1725
2. A.E. Raine, R. Margreiter, and F.P. Brunner Report on management of renal failure in europe, XXII, 1991 Nephrol Dial Transplant 7 suppl 2 1992 7
3. G. Lehmann, U. Ott, and G. Stein Renal osteodystrophy after successful renal transplantation: A histomorphometric analysis in 57 patients Transplantation Proceedings 39 2007 3153
4. K. Borchhardt, I. Sulzbacher, and T. Benesch Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation Am J Transplant 7 2007 2515
5. A. Torres, V. Lorenzo, and E. Salido Calcium metabolism and skeletal problems after transplantation J Am Soc Nephrol 13 2002 551
6. S.M. Sprague, V. Belozeroff, and M.D. Danese Abnormal bone and mineral metabolism in kidney transplant patientsa review Am J Nephrol 28 2008 246
7. R. Ramsey-Goldman, J.E. Dunn, and D.D. Dunlop Increased risk of fracture in patients receiving solid organ transplants J Bone Miner Res 14 1999 456
8. M.Y. Chiu, S.M. Sprague, and D.S. Bruce Analysis of fracture prevalence in kidney-pancreas allograft recipients J Am Soc Nephrol 9 1998 677
9. O.I. Egbuna, J.G. Taylor, and D.A. Bushinsky Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure Clinical Transplantation 21 2007 558
10. K/doqi clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 2003 S1
11. M. Courbebaisse, E. Thervet, and J.C. Souberbielle Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients Kidney Int 75 2009 646
12. G.A. Block, K.J. Martin, and A.L. de Francisco Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis Engl J Med 350 2004 1516
13. M. Peacock, J.P. Bilezikian, and P.S. Klassen Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism J Clin Endocrinol Metab 90 2005 135
14. C. Bergua, J.V. Torregrosa, and D. Fuster Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism Transplantation 86 2008 413
15. K.A. Borchhardt, H. Heinzl, and E. Mayerwoger Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation Transplantation 86 2008 919
16. A.L. Serra, R. Savoca, and A.R. Huber Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients Nephrol Dial Transplant 22 2007 577
17. P. Messa, C. Sindici, and G. Cannella Persistent secondary hyperparathyroidism after renal transplantation Kidney Int 54 1998 1704
18. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation Modification of diet in renal disease study group Ann Intern Med 130 1999 461
19. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephrol 16 1976 31
20. G.G. Brown, R.C. Preisman, and M. Kleerekoper Neurobehavioral symptoms in mild primary hyperparathyroidism: Related to hypercalcemia but not improved by parathyroidectomy Henry Ford Hosp Med J 35 1987 211
21. S.J. Silverberg, M.R. Rubin, and C. Faiman Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma J Clin Endocrinol Metab 92 2007 3803
22. A.M. Ball, D.L. Gillen, and D. Sherrard Risk of hip fracture among dialysis and renal transplant recipients JAMA 288 2002 3014
23. K.A. Hruska, and S.L. Teitelbaum Renal osteodystrophy N Engl J Med 333 1995 166
24. M.C. Monier-Faugere, H. Mawad, and Q. Qi High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation J Am Soc Nephrol 11 2000 1093
25. T. Neveh-Many, and J. Silver Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin d in the rat J Clin Invest 86 1990 1313
26. J.R. Weisinger, and E. Bellorin-Font Magnesium and phosphorus Lancet 352 1998 391
27. F. Caravaca, M.A. Fernandez, and R. Ruiz-Calero Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients Nephrol Dial Transplant 13 1998 2605
28. C. Charytan, J.W. Coburn, and M. Chonchol Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with ckd not receiving dialysis Am J Kidney Dis 45 2005 58
29. D.M. Shoback, J.P. Bilezikian, and S.A. Turner The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism J Clin Endocrinol Metab 88 2003 5644
30. H. Ghanekar, B.J. Welch, and O.W. Moe Post-renal transplantation hypophosphatemia: A review and novel insights Curr Opin Nephrol Hypertens 15 2006 97
31. D.A. Hesselink, R.H. van Schaik, and I.P. van der Heiden Genetic polymorphisms of the cyp3a4, cyp3a5, and mdr-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus Clin Pharmacol Ther 74 2003 245
32. K. Mahalati, and B.D. Kahan Clinical pharmacokinetics of sirolimus Clin Pharmacokinet 40 2001 573
33. D. Padhi, M. Salfi, and M. Emery Cinacalcet does not effect the activity of cytochrome p450 3a enzymes, a metabolic pathway for common immunosuppressive agents: a randomized, open-label, crossover, single-centre study in healthy volunteers Drugs in R&D 9 2008 335
34. P. Falk, N.T. Vethe, and A. Asberg Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycohenolate in renal transplant recipients Nephrol Dial Transplant 23 2008 1048
35. T.J. Hahn, L.R. Halstead, and D.T. Baran Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man J Clin Endocrinol Metab 52 1981 111
36. M.A. Josephson, L.P. Schumm, and M.Y. Chiu Calcium and calcitriol prophylaxis attenuates posttransplant bone loss Transplantation 78 2004 1233
37. K.L. Kavanagh, K. Guo, and J.E. Dunford The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs Proc Natl Acad Sci U S A 103 2006 7829
38. C. Rodd Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues Perit Dial Int 21 suppl 3 2001 S256
39. A. Schwarz, G. Rustien, and S. Merkel Decreased renal transplant function after parathyroidectomy Nephrol Dial Transplant 22 2007 584
40. J.M. El-Amm, M.D. Doshi, and A. Singh Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation Transplantation 83 2007 546
41. A.E. Kruse, U. Eisenberger, and F.J. Frey The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism Nephrol Dial Transplant 20 2005 1311
42. A.L. Serra, A.A. Schwarz, and F.H. Wick Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism Nephrol Dial Transplant 20 2005 1315
43. T.R. Srinivas, J.D. Schold, and K.L. Womer Improvement in hypercalcemia with cinacalcet after kidney transplantation Clin J Am Soc Nephrol 1 2006 323
44. N. Leca, M. Laftavi, and A. Gundroo Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet Am J Transplant 6 2006 2391
45. N. Kamar, I. Gennero, and L. Spataru Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose Nephrol Dial Transplant 23 2008 3720
46. I. Szwarc, A. Argiles, and V. Garrigue Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism Transplantation 82 2006 675